Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Aoya Pharmaceutical is a specialized pharmaceutical company based in Changzhou, China, focusing on the research, development, and manufacturing of high-quality pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company primarily serves the cardiovascular, anti-diabetic, and anti-tumor therapeutic sectors, providing essential components for widely prescribed medications such as Rosuvastatin and Ticagrelor. As a recognized high-tech enterprise, Aoya Pharmaceutical operates GMP-compliant production facilities and maintains a strong emphasis on chemical synthesis and process optimization. The firm offers custom synthesis and contract manufacturing services (CMO/CDMO) to support global pharmaceutical partners in bringing cost-effective treatments to market. Its strategic location in the Jintan Economic Development Zone facilitates efficient logistics and collaboration within China's pharmaceutical manufacturing hub.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 常州奥雅制药.